Home Studies Human Clinical Trial
TXL/THL Human Clinical Trial Print E-mail

The human clinical trials of THL was officially announced in November 2009 by U.S. National Institutes of Health Clinical Trials via website:


Human Clinical Trials of THL

Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer


Sponsor: Taiwan THL Co.LTd.
Collaborator: National Taiwan University Hospital
Information provided by: Taiwan THL Co.LTd.
ClinicalTrials.gov Identifier: NCT00976365


  • Purpose:

    The purpose of this study is to obtain evidence from test article with efficacy in Metastatic Breast Cancer patients. The average of all changes from baseline to post-treatment evaluations in global health/quality of life (QoL) subscale assessed by self-administered European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 (EORTC-QLQ-C30).

    Original website:

    http://clinicaltrials.gov/ct2/show/NCT00976365?term=THL-p&rank=1

  •  

    © 2007-2014 Tombo Enterprise Sdn Bhd. Design by Aftersix Design Studio